Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 38: 2261-2266, 1992;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labeur, C.
Right arrow Articles by Rosseneu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labeur, C.
Right arrow Articles by Rosseneu, M.

Clinical Chemistry, Vol 38, 2261-2266, Copyright © 1992 by American Association for Clinical Chemistry

Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography

C Labeur, D De Bacquer, G De Backer, J Vincke, L Muyldermans, Y Vandekerckhove, E Van der Stichele and M Rosseneu
Innogenetics NV, Ghent, Belgium.

To determine possible associations between lipoprotein(a) [Lp(a)] and the severity of coronary artery lesions, we measured lipid, apolipoprotein, and Lp(a) in a large population of Belgian patients (n = 1054) undergoing coronary angiography. In both women and men, univariate analysis demonstrated significant differences in the Lp(a) concentrations according to the severity of the coronary stenosis. However, after adjustment for possible confounding factors, many of these differences were attenuated, indicating that other variables that differentiate patients from control subjects also influence Lp(a) distribution. Differences in lipid, apolipoprotein, and Lp(a) concentrations between male and female patients are discussed.


The following articles in journals at HighWire Press have cited this article:


Home page
 Hum ReprodHome page
G. Ricci, G. Tamaro, R. Simeone, E. Giolo, G. Nucera, F. De Seta, and S. Guaschino
Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH
Hum. Reprod., March 1, 2001; 16(3): 449 - 456.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Nishino, M. J. Malloy, J. Naya-Vigne, J. Russell, J. P. Kane, and R. F. Redberg
Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 314 - 320.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
B Jorgensen, S Simonsen, K Endresen, K Forfang, T Egeland, A.T Hostmark, and E Thaulow
Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids
Eur. Heart J., October 1, 1999; 20(19): 1407 - 1414.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Su, H. Campos, H. Judge, B. W. Walsh, and F. M. Sacks
Metabolism of Apo(a) and ApoB100 of Lipoprotein(a) in Women: Effect of Postmenopausal Estrogen Replacement
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3267 - 3276.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams
Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2783 - 2792.
[Abstract] [Full Text]

Home page
 CirculationHome page
K. Orth-Gomer, M. A. Mittleman, K. Schenck-Gustafsson, S. P. Wamala, M. Eriksson, K. Belkic, R. Kirkeeide, B. Svane, and L. Ryden
Lipoprotein(a) as a Determinant of Coronary Heart Disease in Young Women
Circulation, January 21, 1997; 95(2): 329 - 334.
[Abstract] [Full Text]

Home page
 CirculationHome page
S. Sunayama, H. Daida, H. Mokuno, H. Miyano, H. Yokoi, Y. J. Lee, H. Sakurai, and H. Yamaguchi
Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women >=55 Years of Age
Circulation, September 15, 1996; 94(6): 1263 - 1268.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
G. Johannsson, J. Oscarsson, T. Rosen, O. Wiklund, G. Olsson, L. Wilhelmsen, and B.-A. Bengtsson
Effects of 1 Year of Growth Hormone Therapy on Serum Lipoprotein Levels in Growth Hormone–Deficient Adults : Influence of Gender and Apo(a) and ApoE Phenotypes
Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2142 - 2150.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
I. C. Klausen, U. Beisiegel, H.-J. Menzel, M. Rosseneu, V. Nicaud, and O. Faergeman
Apo(a) Phenotypes and Lp(a) Concentrations in Offspring of Men With and Without Myocardial Infarction : The EARS Study
Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1001 - 1008.
[Abstract] [Full Text]

Home page
 CirculationHome page
R. L. Desmarais, I. J. Sarembock, C. R. Ayers, S. M. Vernon, E. R. Powers, and L. W. Gimple
Elevated Serum Lipoprotein(a) Is a Risk Factor for Clinical Recurrence After Coronary Balloon Angioplasty
Circulation, March 1, 1995; 91(5): 1403 - 1409.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Association for Clinical Chemistry.